论著癌变畸变突变171CARCINOGENESIS，TERATOGENESIS&MUTAGENESIS2023年5月第35卷第3期(7):4182-4197.[10]ZUIVERLOONTC,TJINSS,BUSSTRAM,etal.OptimizationofnonmuscleinvasivebladdercancerrecurrencedetectionusingaurinebasedFGFR3mutationassay[J].JUrol,2011,186(2):707-712.[11]SHIMJ,MENGXY,LAMYP,etal.APOBEC-mediatedmutagenesisasalikelycauseofFGFR3S249Cmutationover-representationinbladdercancer[J].EurUrol,2019,76(1):9-13.[12]NASKIMC,WANGQ,XUJS,etal.Gradedactivationoffibroblastgrowthfactorreceptor3bymutationscausingachondroplasiaandthanatophoricdysplasia[J].NatGenet,1996,13(2):233-237.[13]BABINAIS,TURNERNC.AdvancesandchallengesintargetingFGFRsignallingincancer[J].NatRevCancer,2017,17(5):318-332.[14]SHIMJ,FONTUGNEJ,MORENO-VEGAA,etal.FGFR3mutationalactivationcaninduceluminal-likepapillarybladdertumorformationandfavorsamalesexbias[J].EurUrol,2023,83(1):70-81.[15]MONTALBOR,IZQUIERDOL,INGELMO-TORRESM,etal.Urinecytologysuspiciousforurothelialcarcinoma:prospectivefollow-upofcasesusingcytologyandurinebiomarker-basedancillarytechniques[J].CancerCytopathol,2020,128(7):460-469.[16]CHRISTENSENE,BIRKENKAMP-DEMTRÖDERK,NORDENTOFTI,etal.LiquidbiopsyanalysisofFGFR3andPIK3CAhotspotmutationsfordiseasesurveillanceinbladdercancer[J].EurUrol,2017,71(6):961-969.[17]MÖHRMANNL,HUANGHJ,HONGDS,etal.Liquidbiopsiesusingplasmaexosomalnucleicacidsandplasmacell-freeDNAcomparedwithclinicaloutcomesofpatientswithadvancedcancers[J].ClinCancerRes,2018,24(1):181-188.[18]MICHAELIDOUK,KOUTOULAKIC,MAVRIDISK,etal.DetectionofKRASG12/G13mutationsincellfree-DNAbydropletdigitalPCR,offersprognosticinformationforpatientswithadvancednon-smallcelllungcancer[J].Cells,2020,9(11):2514.[19]HAYASHIY,FUJITAK,MATSUZAKIK,etal.Clinicalsignificanceofhotspotmutationanalysisofurinarycell-freeDNAinurothelialbladdercancer[J].FrontOncol,2020,10:755.[20]HAYASHIY,FUJITAK,MATSUZAKIK,etal.DiagnosticpotentialofTERTpromoterandFGFR3mutationsinurinarycell-freeDNAinuppertracturothelialcarcinoma[J].CancerSci,2019,110(5):1771-1779.[21]PALACÍN-ALIANAI,GARCÍA-ROMERON,ASENSI-PUIGA,etal.Clinicalutilityofliquidbiopsy-basedactionablemutationsdetectedviaddPCR[J].Biomedicines,2021,9(8):906.[22]CHANGGA,WIGGINSJM,CORLESSBC,etal.TERT,BRAF,andNRASmutationalheterogeneitybetweenpairedprimaryandmetastaticmelanomatumors[J].JInvestDermatol,2020,140(8):1609-1618.[23]KOMPIERLC,LURKINI,VANDERAAMN,etal.FGFR3,HRAS,KRAS,NRASandPIK3CAmutationsinbladdercancerandtheirpotentialasbiomarkersforsurveillanceandtherapy[J].PLoSOne,2010,5(11):e13821.《癌变·畸变·突变》期刊订阅和购买渠道2024年定价15元/册，全年刊期6期，全年定价90元。①各地邮局订阅邮发代号80-285②科学出版社期刊发行部联系电话010-64017032／64017539③网上购买搜淘宝店、微店，店铺名称：中科期刊（订阅及销售过刊）；或扫描右方二维码
